Scholars Central

Mini reviewPublished 29 Feb 2024

Advancements in the Treatment of Paragangliomas and Pheochromocytomas in the Era of Precision Medicine

Authors: Mockler Henk

Journal of Genetics and Genomes

Volume 8 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Paragangliomas and pheochromocytomas are rare neuroendocrine tumors originating from the chromaffin cells of the sympathetic and parasympathetic nervous systems, respectively. While traditionally managed through surgical resection and adjuvant therapies, the advent of precision medicine has revolutionized the approach to diagnosing, treating, and managing these tumors. This article explores the evolving landscape of treatment modalities for paragangliomas and pheochromocytomas in the era of precision medicine.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Genetics and Genomes.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Genetics and Genomes
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Mockler Henk”